THC BioMed Launches THC Kiss Gummies in Recreational and Medical Cannabis Markets

Published: December 16, 2020

THC BioMed Launches THC Kiss Gummies in Recreational and Medical Cannabis Markets

THC BioMed Intl Ltd. is now shipping THC Kiss Gummies to the Canadian recreational and medical  markets. Shipments are beginning with the province of Saskatchewan, with other provinces to follow.

“We are proud to introduce our second cannabis edible product under our Kiss brand to the market and look forward to introducing several more products over the next few months,” said John Miller, President and CEO of THC BioMed.

THC Kiss Gummies are infused using proprietary extraction methods invented by THC BioMed. Each THC Kiss Gummy contains 2.5 mg of THC, with each package containing 4 THC Kiss Gummies.

THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.

Recent News

View All News Items

Latest Article

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

At any step in the cannabis supply chain, your labeling system should allow for full control and traceability, from seed to sale. Implementing lean principles and labeling best practices across the cannabis supply chain can help you streamline your seed-to-sale labeling process and help you gain control.

Click below to read the full blog and learn how to reduce waste, cut costs, and gain efficiency with cannabis labeling: https://bit.ly/2KwZ5IQ

Read Article